RU.521 Chemical Properties

Boiling point:

658.2±65.0 °C(Predicted)

Density 

1.73±0.1 g/cm3(Predicted)

storage temp. 

Keep in dark place,Sealed in dry,Store in freezer, under -20°C

solubility 

Soluble in DMSO (>25 mg/ml)

pka

6.17±0.30(Predicted)

form 

solid

color 

Off-white to pale pink

Stability:

Stable for 1 year from date of purchase as supplied. Solutions in DMSO may be stored at -20°C for up to 2 months.

InChI

InChI=1S/C19H12Cl2N4O3/c1-8-13(16-9-4-2-3-5-10(9)18(27)28-16)17(26)25(24-8)19-22-12-7-6-11(20)14(21)15(12)23-19/h2-7,16,26H,1H3,(H,22,23)

InChIKey

VIQXILLOJLATEF-UHFFFAOYSA-N

SMILES

C1(=O)C2=C(C=CC=C2)C(C2=C(O)N(C3NC4=C(Cl)C(Cl)=CC=C4N=3)N=C2C)O1

RU.521 Usage And Synthesis

Description

RU.521 (2262452-06-0) is an inhibitor of cyclic GMP-AMP synthase (cGAS), an important innate immune system sensor of foreign cytoplasmic double-stranded DNA.1,2 IC50 = 0.70 μM in dsDNA-stimulated RAW macrophages1 and ~0.80 μM in wild type human THP-1 cells2. It is selective for cGAS with no targeting of IFNB1 protein, interferon receptors, or downstream signaling components of the JAK/STAT pathway. RU.521 was able to significantly increase cardiac output in a mouse model of sepsis.3 Active in both mouse and human cell lines.

Biochem/physiol Actions

The potency and selectivity of a chemically improved inhibitor, RU.521, in cellular assays show that while it inhibits cGAS-mediated interferon upregulation, it has reduced to no effect on inflammatory pathways independent of cGAS. Furthermore, RU.521 suppresses the chronically elevated levels of type I interferon observed in primary macrophages from Trex1 null mice, a model of AGS. Crystal structures show that RU.521 occupies the catalytic pocket of murine cGAS, thus interfering with the entry of its ATP and GTP substrates. RU.521 inhibits cytoplasmic DNA-dependent upregulation of IRF3-dependent transcriptional targets only in the presence of an intact cGAS-STING pathway[1-2].

storage

Store at -20°C

References

Vincent et al. (2017), Small molecule inhibition of cGAS reduces interferon expression in primary macrophages from autoimmune mice; Nat. Commun. 8 750 Wiser et al. (2020), Small molecule inhibition of human cGAS reduces total cGAMP output and cytokine expression in cells; Sci. Rep. 10 7604 Xu et al. (2020), Small molecule inhibition of cyclic GMP-AMP synthase ameliorates sepsis-induced cardiac dysfunction in mice; Life Sci. 260 118315
[1] Jessica Vincent. “Small molecule inhibition of cGAS reduces interferon expression in primary macrophages from autoimmune mice.” Nature Communications (2017): 750.
[2] Caroline Wiser. “Small molecule inhibition of human cGAS reduces total cGAMP output and cytokine expression in cells.” Scientific Reports (2020): 7604.

RU.521(2262452-06-0)Related Product Information

• KU57788(NU7441)
• 3-[(Aminocarbonyl)amino]-5-(3-fluorophenyl)-N-(3S)-3-piperidinyl-2-Thiophenecarboxamide
• Tigecycline
• Dequalinium chloride